Our Science
Pioneering Discovery Of Novel Therapeutics
VRise is a precision oncology company pursuing ground-breaking discovery and development of novel small molecules. We use a proprietary discovery engine to target pathways that determine cancer growth, proliferation and differentiation.
We combine cutting-edge technology with a lean development methodology through our global research resources in India, UK and the US. This enables us to accelerate the development of novel cancer therapeutics at a rapid pace. This approach has been validated with the discovery of a portfolio of diverse and highly promising therapeutics.
CLEAR PATH TO MARKET
High Unmet Need
We work in areas with significant need with accelerated pathway potential
PATIENT FOCUSED
Breakthrough Driven
We select opportunities that have the potential to deliver breakthrough therapies for patients
ENGAGING WITH NEW RESEARCH
Novel Therapeutic Targets
We work in promising new research areas integrating cutting-edge tools to explore new avenues in the fight against cancer.
PERSONALISED MEDICINE
Biomarker Guided
We focus on biomarker driven targets and build-in companion diagnostics to accelerate and de-risk the development process.
Advance the Next Generation of Targeted Therapies
We welcome strategic collaborations from academics and institutional organizations interested in supporting our novel discoveries against cancer.
